Indeks Rilis Pers English

Castrol ON PG25 cooling fluids validated for NVIDIA AI factory and data centre infrastructure
PR Newswire
Selasa, 18 Agt

Castrol ON PG25 cooling fluids validated for NVIDIA AI factory and data centre infrastructure

Introducing Nearmap Labs: A Window into the Future of Property Intelligence
PR Newswire
Selasa, 18 Agt

Introducing Nearmap Labs: A Window into the Future of Property Intelligence

Yalla Group Limited Announces Unaudited Second Quarter 2026 Financial Results
PR Newswire
Selasa, 18 Agt

Yalla Group Limited Announces Unaudited Second Quarter 2026 Financial Results

Aon Announces CFO Transition
PR Newswire
Selasa, 18 Agt

Aon Announces CFO Transition

HCLTech report reveals telecom leaders identify AI as top revenue driver, but only 25% ready to scale
PR Newswire
Senin, 17 Agt

HCLTech report reveals telecom leaders identify AI as top revenue driver, but only 25% ready to scale

Yeahka Limited to Report 2026 Interim Results on Thursday, August 27, 2026
PR Newswire
Senin, 17 Agt

Yeahka Limited to Report 2026 Interim Results on Thursday, August 27, 2026

Mini storage provider Restore expands to Tsuen Wan, now with 40+ stores across Hong Kong
PR Newswire
Senin, 17 Agt

Mini storage provider Restore expands to Tsuen Wan, now with 40+ stores across Hong Kong

DG Display Showcase Helps Wongs Jewellers' Manchester Store Reach UK Store Design of the Year Shortlist
PR Newswire
Senin, 17 Agt

DG Display Showcase Helps Wongs Jewellers' Manchester Store Reach UK Store Design of the Year Shortlist

XPPen Unveils Artist Ultra 14, Bringing Professional Drawing Performance to a More Portable Form Factor
PR Newswire
Senin, 17 Agt

XPPen Unveils Artist Ultra 14, Bringing Professional Drawing Performance to a More Portable Form Factor

Mavrix Makes the Case for Trusted Human Evidence in the AI Era at Quirk's New York
PR Newswire
Senin, 17 Agt

Mavrix Makes the Case for Trusted Human Evidence in the AI Era at Quirk's New York

Poolking Advances Fiberglass Sand Filter Technology for Large-Scale Water Treatment Projects
PR Newswire
Senin, 17 Agt

Poolking Advances Fiberglass Sand Filter Technology for Large-Scale Water Treatment Projects

H World Group Reports Strong Second-Quarter 2026 Performance and Announces New Shareholder Return Plan
PR Newswire
Senin, 17 Agt

H World Group Reports Strong Second-Quarter 2026 Performance and Announces New Shareholder Return Plan

GROWNSY Launches "Ask a Pediatrician: Baby Congestion" Educational Content with Dr. Molly O'Shea
PR Newswire
Senin, 17 Agt

GROWNSY Launches "Ask a Pediatrician: Baby Congestion" Educational Content with Dr. Molly O'Shea

Connext Completes Enrollment in Phase 2 Trial of CNT201 in Dupuytren's Contracture
PR Newswire
Senin, 17 Agt

Connext Completes Enrollment in Phase 2 Trial of CNT201 in Dupuytren's Contracture

AliExpress Enhances U.S. Shopping Experience Ahead of 2026 Back-to-School Sale
PR Newswire
Senin, 17 Agt

AliExpress Enhances U.S. Shopping Experience Ahead of 2026 Back-to-School Sale

U.S. Recruitment for Ohio State University Study Evaluating EmeTerm in Adults With Chronic Nausea and Vomiting
PR Newswire
Senin, 17 Agt

U.S. Recruitment for Ohio State University Study Evaluating EmeTerm in Adults With Chronic Nausea and Vomiting

Uniphore Launches Marketing AI to Usher in New Era: NYSE Content Update
PR Newswire
Senin, 17 Agt

Uniphore Launches Marketing AI to Usher in New Era: NYSE Content Update

Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths
PR Newswire
Senin, 17 Agt

Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths

GEEKOM Pushes the Boundaries of Mini PC Innovation with Four-Node A9 Mega AI Cluster
PR Newswire
Senin, 17 Agt

GEEKOM Pushes the Boundaries of Mini PC Innovation with Four-Node A9 Mega AI Cluster

OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors
PR Newswire
Senin, 17 Agt

OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors